These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 10930890)

  • 21. New-generation proton pump inhibitors: overcoming the limitations of early-generation agents.
    Robinson M
    Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S43-7. PubMed ID: 11430508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review article: pH, healing and symptom relief with rabeprazole treatment in acid-related disorders.
    Robinson M
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():30-7. PubMed ID: 15496216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.
    Li XQ; Andersson TB; Ahlström M; Weidolf L
    Drug Metab Dispos; 2004 Aug; 32(8):821-7. PubMed ID: 15258107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole.
    Bown RL
    Int J Clin Pract; 2002 Mar; 56(2):132-9. PubMed ID: 11926700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of rabeprazole once daily for acid-related disorders.
    Lanza F; Bardhan KD; Perdomo C; Niecestro R; Barth J
    Dig Dis Sci; 2001 Mar; 46(3):587-96. PubMed ID: 11318537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharma-clinics medication of the month. Rabeprazole (Pariet)].
    Louis E
    Rev Med Liege; 2002 Jan; 57(1):53-6. PubMed ID: 11899500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotherapy for acid/peptic disorders.
    Schubert ML
    Yale J Biol Med; 1996; 69(2):197-201. PubMed ID: 9112751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
    Bardou M
    Rev Prat; 2001 Apr; 51(7):789-95. PubMed ID: 11387678
    [No Abstract]   [Full Text] [Related]  

  • 30. Rabeprazole for the treatment of acid-related disorders.
    Marelli S; Pace F
    Expert Rev Gastroenterol Hepatol; 2012 Aug; 6(4):423-35. PubMed ID: 22928894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [All proton pump inhibitors are equally efficacious in standard dosages].
    Hellström PM; Vitols S
    Lakartidningen; 2003 Jun; 100(25):2212-6. PubMed ID: 12872509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Proton pump inhibitors, a family of drugs in continuous expansion].
    Pellicano R
    Minerva Gastroenterol Dietol; 2000 Dec; 46(4):231-41. PubMed ID: 19320085
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of lansoprazole in eradication of Helicobacter pylori.
    Takimoto T; Ido K; Taniguchi Y; Satoh K; Saifuku K; Kihira K; Yoshida Y; Kimura K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S121-4. PubMed ID: 7594327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New perspectives in gastric acid suppression: genetic polymorphisms predict the efficacy of proton pump inhibitors.
    Egan LJ; Murray JA
    Dig Dis; 2000; 18(2):58-63. PubMed ID: 11060468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know.
    Robinson M; Horn J
    Drugs; 2003; 63(24):2739-54. PubMed ID: 14664653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton pump inhibitors.
    Katelaris PH
    Med J Aust; 1998 Aug; 169(4):208-11. PubMed ID: 9734580
    [No Abstract]   [Full Text] [Related]  

  • 37. Review article: the continuing development of proton pump inhibitors with particular reference to pantoprazole.
    Huber R; Kohl B; Sachs G; Senn-Bilfinger J; Simon WA; Sturm E
    Aliment Pharmacol Ther; 1995 Aug; 9(4):363-78. PubMed ID: 8527612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review article: the pharmacology of rabeprazole.
    Williams MP; Pounder RE
    Aliment Pharmacol Ther; 1999 Aug; 13 Suppl 3():3-10. PubMed ID: 10491723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton pump inhibitors in children: a review.
    Marchetti F; Gerarduzzi T; Ventura A
    Dig Liver Dis; 2003 Oct; 35(10):738-46. PubMed ID: 14620626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing acid suppression for treatment of acid-related diseases.
    Hunt RH; Cederberg C; Dent J; Halter F; Howden C; Marks IN; Rune S; Walt RP
    Dig Dis Sci; 1995 Feb; 40(2 Suppl):24S-49S. PubMed ID: 7859582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.